TherOx Downstream System
Zoll Circulation, Inc. · Decision date Oct 29, 2025
What did the FDA decide?
FDA records P170027/S020 as a supplement to PMA P170027, with the supplement type “30-Day Notice”. The recorded decision is OK30 (30-day notice), dated Oct 29, 2025.
FDA approval order statement
approval of cleaning solution change for TherOx DownStream Cartridge Components due to current solution obsolescence
- Regulatory pathway
- PMA supplement
- Supplement type
- 30-Day Notice
- Clinical specialty
- Cardiovascular
- Decision date
- Oct 29, 2025
- FDA change category
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
Regulatory record facts
- Identifier
- P170027/S020
- Regulatory pathway
- PMA supplement
- Applicant
- Zoll Circulation, Inc.
- Product code
- MWG
- Decision code
- OK30
- Decision date
- Oct 29, 2025
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: System, oxygen, aqueous.
- Applicant
- Zoll Circulation, Inc.
- Product code
- MWG
- FDA device class
- 3
Review the original FDA PMA listing for the original approval scope and linked supplements.
FDA decision timeline
P170027/S020 received
Application receipt date recorded by FDA.
P170027/S020 · FDA decision
30-Day Notice
P170027/S018 · Related supplement
TherOx Downstream System
Timeline entries are records held by MedtechLedger for P170027. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P170027
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
TherOx Downstream SystemP170027/S018 | Zoll Circulation, Inc. | PMA supplement | Apr 10, 2026 | FDA |
Regulatory context
A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Zoll Circulation, Inc.
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- 2000 Ringwood Ave., San Jose, CA, 95131
Sources and methodology
- Original FDA record: P170027/S020
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 21, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records